UPS Earnings Show The Weight Of $170,000 Salaries While It Learns To Navigate Shipping Slump
UPS delivers mixed Q1 results, with lower revenue and profit due to slower business. Recent salary negotiations also affected finances. read more.....»»
Cleveland-Cliffs, Freeport-McMoRan Report Q1 Results; Worthington Steel Gets GM Supplier Of The Year And More: Tuesday"s Top Mining Stories
Cleveland-Cliffs And Freeport-McMoRan Report Q1 Results; Worthington Steel Gets GM Supplier Of The Year And More: Tuesday's Top Mining Stories read more.....»»
Karol G, Peso Pluma Propel US Latin Music Revenue To New Heights, Reaches $1.4B
Dive into the $1.4 billion US Latin music market surge. Discover how stars like Karol G and Peso Pluma are leading the charge. read more.....»»
Decoding Fair Isaac"s Options Activity: What"s the Big Picture?
read more.....»»
"We"re Buying This Soft Landing": Former Fed Governor Blames Government Spending For Delaying Rate Cuts
Robert Kaplan critiques U.S. fiscal policies, stating they hinder Fed's ability to cut rates amidst inflation. Risk of high rates and debt. read more.....»»
What"s Going On With Netflix Shares?
Netflix shares are trading higher by 4.1% during Tuesday's session. The stock is rebounding after its recent earnings report. read more.....»»
Enphase Energy Q1 Earnings: Revenue, EPS Come In Below Estimates Amid "Softening" US Demand
Enphase Energy reported first-quarter revenue of $263.3 million, which missed the consensus estimate of $281.95 million, according to Benzinga Pro. read more.....»»
Visa Shares Rise After Better-Than-Expected Q2 Results
Visa reported quarterly adjusted earnings of $2.51 per share which beat the analyst consensus estimate of $2.44 by 2.87%. read more.....»»
IBM"s Moment Of Truth As Earnings Expected To Impress With Strong AI Influence, Analyst Says
IBM (NYSE:IBM) reports Q1 earnings on April 24, with EPS of $1.59 and $14.6B in revenues expected. Stock up 45% in past year. BofA analyst maintains Buy rating and $220 price target. Latest Rati.....»»
Why Sunrun, SolarEdge, Sunnova Energy Shares Are Moving Lower After Hours
Several solar stock.....»»
Non-Compete Clauses Are A Thing Of The Past, At Least For Now: FTC Issues Landmark Ban, Chamber Of Commerce Plans To Sue
Non-compete agreements nationwide were banned by the FTC in a three-to-two vote. The U.S. Chamber of Commerce is clapping back. read more.....»»
Study Finds Unsafe Levels Of Toxic Metals In Commercially Available Cannabis Rolling Papers
Cannabis users may be inhaling harmful metals from rolling papers. Study found alarming levels in 53 popular papers, posing health risks. read more.....»»
Bonds & Stocks Bid As "Bad News"-Buyers Trump CTA-Sellers
Bonds & Stocks Bid As 'Bad News'-Buyers Trump CTA-Sellers 'Bad news' was certainly good news today as 'soft' survey data showed the US Manufacturing sector dropping back into contraction (.....»»
Tesla Soars: Misses Across The Board, But Is "Accelerating" Rollout Of "More Affordable Models"
Tesla Soars: Misses Across The Board, But Is "Accelerating" Rollout Of "More Affordable Models" As previewed earlier, today's TSLA print is likely to be ugly: the company is the only Mag7 member expected to r.....»»
2nd Democrat Congressman Sued For Defamation By Ex-Biden Associate Tony Bobulinski
2nd Democrat Congressman Sued For Defamation By Ex-Biden Associate Tony Bobulinski Authored by Zachary Stieber via The Epoch Times (emphasis ours).....»»
WTI Holds Gains After API Reports Unexpected Crude Inventory Draw
WTI Holds Gains After API Reports Unexpected Crude Inventory Draw Oil priced ended notably higher today after recovering .....»»
Cryptocurrency Pepe Up More Than 15% In 24 hours
Over the past 24 hours, Pepe's (CRYPTO: PEPE) price rose 15.13% to $0.0000077. This continues its positive trend over the past week where it has experienced a 46.0% gain, moving from $0.0000053 to its current price. read more.....»»
Cryptocurrency dogwifhat"s Price Increased More Than 7% Within 24 hours
Over the past 24 hours, dog.....»»
Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
Incyte acquires Escient Pharmaceuticals for $750 million, bolstering its pipeline. Cantor Fitzgerald initiates coverage with a Neutral rating, citing undervaluation concerns despite strong cash flow. Latest Ratings for INCY DateFirmActio.....»»